536 related articles for article (PubMed ID: 25348783)
1. Comparison of mRNA, Protein, and Urinary Nucleic Acid Levels of S100A8 and S100A9 between Prostate Cancer and BPH.
Yun SJ; Yan C; Jeong P; Kang HW; Kim YH; Kim EA; Lee OJ; Kim WT; Moon SK; Kim IY; Choi YH; Kim WJ
Ann Surg Oncol; 2015 Jul; 22(7):2439-45. PubMed ID: 25348783
[TBL] [Abstract][Full Text] [Related]
2. Urinary Nucleic Acid TSPAN13-to-S100A9 Ratio as a Diagnostic Marker in Prostate Cancer.
Yan C; Kim YH; Kang HW; Seo SP; Jeong P; Lee IS; Kim D; Kim JM; Choi YH; Moon SK; Yun SJ; Kim WJ
J Korean Med Sci; 2015 Dec; 30(12):1784-92. PubMed ID: 26713053
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia and HIF-1 increase S100A8 and S100A9 expression in prostate cancer.
Grebhardt S; Veltkamp C; Ströbel P; Mayer D
Int J Cancer; 2012 Dec; 131(12):2785-94. PubMed ID: 22505354
[TBL] [Abstract][Full Text] [Related]
4. Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer.
Hermani A; Hess J; De Servi B; Medunjanin S; Grobholz R; Trojan L; Angel P; Mayer D
Clin Cancer Res; 2005 Jul; 11(14):5146-52. PubMed ID: 16033829
[TBL] [Abstract][Full Text] [Related]
5. Proteins S100A8 and S100A9 are potential biomarkers for renal cell carcinoma in the early stages: results from a proteomic study integrated with bioinformatics analysis.
Zhang L; Jiang H; Xu G; Wen H; Gu B; Liu J; Mao S; Na R; Jing Y; Ding Q; Zhang Y
Mol Med Rep; 2015 Jun; 11(6):4093-100. PubMed ID: 25673070
[TBL] [Abstract][Full Text] [Related]
6. PPM1D as a novel biomarker for prostate cancer after radical prostatectomy.
Jiao L; Shen D; Liu G; Jia J; Geng J; Wang H; Sun Y
Anticancer Res; 2014 Jun; 34(6):2919-25. PubMed ID: 24922655
[TBL] [Abstract][Full Text] [Related]
7. S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells.
Hermani A; De Servi B; Medunjanin S; Tessier PA; Mayer D
Exp Cell Res; 2006 Jan; 312(2):184-97. PubMed ID: 16297907
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of S100A8 and S100A9 expression in gastric cancer].
Hu Y; Fan B; Zhang LH; Cheng XJ; Niu ZJ; Ji JF
Zhonghua Yi Xue Za Zhi; 2013 Nov; 93(42):3369-74. PubMed ID: 24418034
[TBL] [Abstract][Full Text] [Related]
9. S100A8, S100A9, and the S100A8/A9 complex in circulating blood are not associated with prostate cancer risk-A re-evaluation study.
Ludwig S; Stephan C; Lein M; Loening SA; Jung K
Prostate; 2007 Sep; 67(12):1301-7. PubMed ID: 17626245
[TBL] [Abstract][Full Text] [Related]
10. Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells.
Le Magnen C; Bubendorf L; Ruiz C; Zlobec I; Bachmann A; Heberer M; Spagnoli GC; Wyler S; Mengus C
Eur J Cancer; 2013 Mar; 49(4):955-63. PubMed ID: 23089465
[TBL] [Abstract][Full Text] [Related]
11. Expression of surfactant protein-C, S100A8, S100A9, and B cell markers in renal allografts: investigation of the prognostic value.
Eikmans M; Roos-van Groningen MC; Sijpkens YW; Ehrchen J; Roth J; Baelde HJ; Bajema IM; de Fijter JW; de Heer E; Bruijn JA
J Am Soc Nephrol; 2005 Dec; 16(12):3771-86. PubMed ID: 16251238
[TBL] [Abstract][Full Text] [Related]
12. Impact of S100A8/A9 expression on prostate cancer progression in vitro and in vivo.
Grebhardt S; Müller-Decker K; Bestvater F; Hershfinkel M; Mayer D
J Cell Physiol; 2014 May; 229(5):661-71. PubMed ID: 24122301
[TBL] [Abstract][Full Text] [Related]
13. Expression analysis of osteopontin mRNA splice variants in prostate cancer and benign prostatic hyperplasia.
Tilli TM; Thuler LC; Matos AR; Coutinho-Camillo CM; Soares FA; da Silva EA; Neves AF; Goulart LR; Gimba ER
Exp Mol Pathol; 2012 Feb; 92(1):13-9. PubMed ID: 21963599
[TBL] [Abstract][Full Text] [Related]
14. [Possibility of formation of the S100A8/A9-proinflammatory cytokine complexes in vivo in acute inflammation and their functional roles].
Ishihara K; Namura T; Murayama H; Arai S; Totani M; Ikemoto M
Rinsho Byori; 2009 Apr; 57(4):324-31. PubMed ID: 19489433
[TBL] [Abstract][Full Text] [Related]
15. Overexpressed Rce1 is positively correlated with tumor progression and predicts poor prognosis in prostate cancer.
Huang L; Li M; Wang D; He J; Wu W; Zeng Q; Li J; Xiao M; Hu J; He Y; Li Y; Mai L; Liu W
Hum Pathol; 2016 Jan; 47(1):109-14. PubMed ID: 26546252
[TBL] [Abstract][Full Text] [Related]
16. S100A8 and S100A9 Are Important for Postnatal Development of Gut Microbiota and Immune System in Mice and Infants.
Willers M; Ulas T; Völlger L; Vogl T; Heinemann AS; Pirr S; Pagel J; Fehlhaber B; Halle O; Schöning J; Schreek S; Löber U; Essex M; Hombach P; Graspeuntner S; Basic M; Bleich A; Cloppenborg-Schmidt K; Künzel S; Jonigk D; Rupp J; Hansen G; Förster R; Baines JF; Härtel C; Schultze JL; Forslund SK; Roth J; Viemann D
Gastroenterology; 2020 Dec; 159(6):2130-2145.e5. PubMed ID: 32805279
[TBL] [Abstract][Full Text] [Related]
17. S100A8/A9 mRNA induction in an ex vivo model of endotoxin tolerance: roles of IL-10 and IFNγ.
Fontaine M; Planel S; Peronnet E; Turrel-Davin F; Piriou V; Pachot A; Monneret G; Lepape A; Venet F
PLoS One; 2014; 9(6):e100909. PubMed ID: 24956170
[TBL] [Abstract][Full Text] [Related]
18. S100A9 has a protective role in inflammation-induced skin carcinogenesis.
McNeill E; Hogg N
Int J Cancer; 2014 Aug; 135(4):798-808. PubMed ID: 24436096
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 stimulates S100A8 expression by activating protein kinase A and CCAAT/enhancer-binding-protein-beta in prostate cancer cells.
Miao L; Grebhardt S; Shi J; Peipe I; Zhang J; Mayer D
Int J Biochem Cell Biol; 2012 Nov; 44(11):1919-28. PubMed ID: 22728165
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of calcium-binding protein S100A8 and S100A9 expression in non-small cell lung cancer.
Huang H; Huang Q; Tang T; Gu L; Du J; Li Z; Lu X; Zhou X
Thorac Cancer; 2018 Jul; 9(7):800-804. PubMed ID: 29733516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]